汉诺医疗冲刺科创板：上半年营收3735万，亏8227万，拟募资10.6亿，迈瑞是股东

Core Viewpoint - Shenzhen Hanno Medical Technology Co., Ltd. has submitted its prospectus for an IPO on the Sci-Tech Innovation Board, aiming to raise approximately 1.062 billion yuan for various projects and working capital [3][18]. Group 1: Fundraising and Investment Plans - Hanno Medical plans to raise 1.062 billion yuan, with allocations including 500 million yuan for the R&D center, 200 million yuan for the production base, 109 million yuan for marketing network construction, and 250 million yuan for working capital [4][20]. - The total investment for the R&D center project is 502.88 million yuan, while the production base project is estimated at 200.66 million yuan [4][20]. Group 2: Financial Performance - In the first half of 2025, Hanno Medical reported revenues of 37.35 million yuan and a net loss of 82.27 million yuan [5][21]. - The company’s revenue for 2022, 2023, and 2024 was 0 yuan, 29.83 million yuan, and 49.31 million yuan respectively, with net losses of 64.79 million yuan, 340 million yuan, and 183 million yuan [5][22]. - The asset-liability ratio for 2025 is projected at 72.36%, up from 31.96% in 2022, indicating increasing financial leverage [7][22]. Group 3: Product Pipeline and Focus - Hanno Medical specializes in high-end innovative medical devices, focusing on Extracorporeal Life Support (ECLS) technology, providing stable and reliable circulatory support and oxygenation products [5][21]. - The company has a product pipeline that includes solutions for Extracorporeal Membrane Oxygenation (ECMO), Extracorporeal Cardiopulmonary Resuscitation (ECPR), and Low-Flow Extracorporeal Circulation Support Systems [6][21]. Group 4: Shareholding Structure - Before the IPO, the major shareholders include Beijing Hanno with 24.85%, LI YIJIANG with 10.36%, and other investors such as Baoxing Yili and Daotong holding 9.69% and 7.51% respectively [8][12]. - Post-IPO, Beijing Hanno's shareholding will decrease to 18.64%, while LI YIJIANG's will drop to 7.77% [12][30].